@article{6e78355dcb7e48358e1b18840bef5877,
title = "Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA*008 to Escape Elimination by NK Cells",
abstract = "Natural killer (NK) cells mediate innate immune responses against hazardous cells and are particularly important for the control of human cytomegalovirus (HCMV). NKG2D is a key NK activating receptor that recognizes a family of stress-induced ligands, including MICA, MICB, and ULBP1-6. Notably, most of these ligands are targeted by HCMV proteins and a miRNA to prevent the killing of infected cells by NK cells. A particular highly prevalent MICA allele, MICA*008, is considered to be an HCMV-resistant {"}escape variant{"} that confers advantage to human NK cells in recognizing infected cells. However, here we show that HCMV uses its viral glycoprotein US9 to specifically target MICA*008 and thus escapes NKG2D attack. The finding that HCMV evolved a protein dedicated to countering a single host alleleillustrates the dynamic co-evolution of host and pathogen.",
author = "Einat Seidel and Le, {Vu Thuy Khanh} and Yotam Bar-On and Pinchas Tsukerman and Jonatan Enk and Rachel Yamin and Natan Stein and Dominik Schmiedel and Esther OiknineDjian and Yiska Weisblum and Boaz Tirosh and Peter Stastny and Wolf, {Dana G.} and Hartmut Hengel and Ofer Mandelboim",
note = "Funding Information: We thank Cosima Zimmermann for providing HCMV stocks. This study was supported by the European Research Council under the European Union{\textquoteright}s Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement number 320473-BacNK BacNK and by the European Union FP7 grant-316655 (VACTRAIN). Additional support came from the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation and by the I-Core on Chromatin and RNA in Gene Regulation, the GIF Foundation, the Lewis Family Foundation, the Israel Cancer Research Fund professorship grant, the Israeli Science Foundation, the Helmholtz Israel grant and the Rosetrees Trust (all to O.M.) and VISTRIE VH-VI-242 (to H.H.). O.M. is a Crown Professor of Molecular Immunology. E.S. is supported by the Adams Fellowship Programme of the Israel Academy of Sciences and Humanities and by the Foulkes Foundation. D.S. receives funding from the People Programme (Marie Curie Actions) of the European Union{\textquoteright}s Seventh Framework Programme FP7 (FP7-PEOPLE-2012-ITN-317013). Publisher Copyright: {\textcopyright} 2015 The Authors.",
year = "2015",
month = feb,
day = "17",
doi = "10.1016/j.celrep.2015.01.029",
language = "English (US)",
volume = "10",
pages = "968--982",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "6",
}